Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Monica Bertagnolli

Surgical Oncology · Harvard Medical School

View

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Todd Rosengart

Cardiac Surgery · BCM

View

Dr. Larry Kaiser

Thoracic Surgery · UPenn

View

Dr. Neri Cohen

Thoracic Surgery · XVIVO

View

Dr. Jad M Abdelsattar, M.D, FACS

Breast Surgical Onc · University of Oxford

View

Dr. Lauren Kopicky

Breast Surgical Onc · Cleveland Clinic

View

Dr. Jennifer Plichta

Breast Surgical Onc · Duke University

View

Dr. Sarah Blair

Breast Surgical Onc · UCSD

View

Dr. Karen Goodwin

Breast Surgical Onc · UCSF

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Understanding Curability and Life Expectancy in Surgical Patients with Advanced Cancer: A Mixed Methods Analysis of Factors that Affect Views on Cancer Prognosis.

    Jul 7, 2025DOI: 10.1245/s10434-025-17768-xJournal ArticleASO

    Written by: Beatrice J SunEmily M PangTiffany M YueByrne Lee

    Find these authors on Roon

    BS
    Dr. Beatrice Sun
    Surgical Oncology · Stanford

    Summary

    BACKGROUND: Expectations about disease prognosis are challenging and understudied in patients with advanced cancers. We evaluateed patient factors associated with prognostic understanding in this population.METHODS: In this explanatory sequential mixed methods study, surveys were administered to patients with advanced-stage cancer who were seen in the surgical oncology clinic (2022-2024); a subset of patients underwent semistructured interviews. Perceived disease curability and life expectancy were compared between the patient and surgeon: the patient's prognostic rating equal to or less optimistic than their surgeon's was categorized as "concordant," whereas a higher rating was "discordant" and reflected an optimistic outlook.RESULTS: In total, 165 surveys were completed. Median age was 58 years. The most common primary malignancies were appendiceal, colorectal, and gynecologic. Median time since cancer diagnosis was 18 months. Overall, 32% of patients demonstrated concordant views on curability, whereas 60% were concordant on life expectancy. Patients who had children younger than 18 years were more optimistic about disease curability and more discordant with their surgeon (84% vs. 62% discordant, p = 0.007). Additionally, patients who had lived beyond 1 year since cancer diagnosis were more optimistic about life expectancy (47% vs. 27% discordant, p = 0.012). Qualitative analysis revealed that the responsibility to nurture their children; hope of living long-term with cancer; and perspective to live in the moment were reasons to maintain an optimistic outlook.CONCLUSIONS: Our study illustrates the discordance between patient-surgeon views on curability and life expectancy in advanced cancer, while highlighting the importance of understanding patient factors that may influence their outlook on cancer.
    BSDr. Beatrice Sun

    Dr. Beatrice Sun

    Surgery · Surgical Oncology
    Stanford Medicine
    beatrice